Prothena reported 555.62M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Akebia Therapeutics AKBA:US $ 302.69M 30.68M
ALKERMES ALKS:US 1.01B 47.34M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Amgen AMGN:US $ 18520M 865M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Exelixis EXEL:US $ 1842.74M 8M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Macrogenics MGNX:US $ 218.2M 61.36M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Prothena PRTA:US 555.62M 29.19M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
Vital Therapies VTL:US $ 115.88M 10.89M
Xoma XOMA:US $ 89.61M 7.36M
YTE INCY:US $ 3288.09M 169.42M